Copyright
©The Author(s) 2021.
World J Clin Cases. Jan 26, 2021; 9(3): 651-658
Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.651
Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.651
Table 1 Antimicrobial susceptibility testing for Acinetobacter baumannii in cerebrospinal fluid
| Antibiotic | Susceptibility | MIC (mg/L) |
| Amikacin | R | > 32 |
| Ceftriaxone | I | > 32 |
| Cefotaxime | R | > 32 |
| Ceftazidime | R | > 16 |
| Cefepime | R | > 16 |
| Tetracycline | R | > 8 |
| Levofloxacin | R | > 4 |
| Selectrin | R | > 2 |
| Piperacillin | R | > 64 |
| Tigecycline | S | |
| Gentamicin | R | > 8 |
| Ciprofloxacin | R | > 2 |
| Tobramycin | R | > 8 |
| Meropenem | R | > 8 |
| Ticarcillin | R | > 64 |
- Citation: Li W, Li DD, Yin B, Lin DD, Sheng HS, Zhang N. Successful treatment of pyogenic ventriculitis caused by extensively drug-resistant Acinetobacter baumannii with multi-route tigecycline: A case report. World J Clin Cases 2021; 9(3): 651-658
- URL: https://www.wjgnet.com/2307-8960/full/v9/i3/651.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i3.651